Showing results (91-100 of 144) with videos related to
Sort By:
Pageof 15
Journal of Clinical Gastroenterology|January 19, 2011
Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose "escalation" in patients losing responseMaría Chaparro, Julián Panes, Valle García, et al.Gastroenterologia Y Hepatologia|March 28, 2015
Information resources used by patients with inflammatory bowel disease: Satisfaction, expectations and information gapsIgnacio Catalán-Serra, Jose María Huguet-Malavés, Miguel Mínguez, et al.Journal of Crohn'S & Colitis|November 13, 2012
Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcomeOrlando García-Bosch, Javier P Gisbert, Alex Cañas-Ventura, et al.Gastroenterologia Y Hepatologia|February 22, 2025
Position statement of the Spanish Society of Primary Care Physicians (SEMERGEN) and Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the management of inflammatory bowel disease in Primary CareDaniel Ginard, Noelia Fontanillas, Iria Bastón-Rey, et al.Semergen|January 20, 2025
[Position statement of the Spanish Society of Primary Care Physicians (SEMERGEN) and Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the management of inflammatory bowel disease in Primary Care]Daniel Ginard, Noelia Fontanillas, Iria Bastón-Rey, et al.Journal of Crohn'S & Colitis|May 13, 2022
Multicriteria Decision Analysis for Updating of Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units in SpainXavier Calvet, Julián Panés, Javier Gallardo-Escudero, et al.Journal of Crohn'S & Colitis|June 8, 2026
Risk of symptomatic leishmaniasis in patients with inflammatory bowel disease receiving biologic therapy in an endemic Mediterranean region: a population-based case-control studyLeticia Gimeno-Pitarch, Marisa Iborra, Ana Crespo, et al.International Journal of Molecular Sciences|December 23, 2022
The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn's DiseaseMarisa Iborra, Inés Moret, Enrique Busó, et al.Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|March 9, 2019
The Harvey-Bradshaw Index Adapted to a Mobile Application Compared with In-Clinic Assessment: The MediCrohn StudyAna Echarri, Isabel Vera, Virginia Ollero, et al.Scandinavian Journal of Gastroenterology|November 7, 2023
Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohortMarisa Iborra, Rocio Ferreiro-Iglesias, Martín-Arranz Maria Dolores, et al.Pageof 15